Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients—results of KRANIOPHARYNGEOM 2007
Authors:
- Carsten FriedrichCFCarsten Friedrich
- Svenja BoekhoffSBSvenja Boekhoff
- Martin BischoffMBMartin Bischoff
- Julia BeckhausJBJulia Beckhaus
- Panjarat SowithayasakulPSPanjarat Sowithayasakul
- Gabriele CalaminusGCGabriele Calaminus
- Maria EveslageMEMaria Eveslage
- Chiara ValentiniCVChiara Valentini
- Brigitte BisonBBBrigitte Bison
- Semi B. HarrabiSHSemi B. Harrabi
- Mechthild KrauseMKMechthild Krause
- Beate TimmermannBTBeate Timmermann
Open Access
- 27 October 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1180993
Abstract
Background: Proton beam therapy (PBT) is being increas16ingly used to treat residual craniopharyngioma (CP) after hypothalamus-sparing surgery. Compared to photon-based radiation therapy (XRT) with PBT, less irradiation in the penumbra reduces the scattered dose to critical organs neighboring but outside the area of treatment, minimizing the risk of sequelae.Patients and methods: Between 2007 and 2019, 99 of 290 (34%) childhood-onset CP patients recruited in KRANIOPHARYNGEOM 2007 received external radiation therapy (RT) (65% PBT, 35% XRT). Outcome was analyzed in terms of survival, endocrinological and anthropometric parameters (BMI and height SDS), quality of life (QoL using PEDQOL), and functional capacity (FMH) with special regard to irradiation technique.Results: PBT became predominant (used in 43% and 72% of all irradiated patients registered within the first and second halves of the recruitment period, between 2008 and 2013 and 2013 and 2018, respectively). Five-year event-free survival rates after PBT or XRT were comparable (92% ± 4% vs. 91% ± 4%, p = 0.42) and higher than for the whole cohort since diagnosis, including non-RT patients (37% ± 4%). Radiation doses to the hypothalamus and pituitary did not differ between PBT and XRT. Endocrine deficits due to disturbances of the hypothalamic-pituitary axis (HPA) were already common before irradiation. During the first 5 years after CP diagnosis/RT, no differences between PBT, XRT, and non-RT CP patients concerning functional capacity and anthropometric parameters have been obtained. Only for the PEDQOL domain “physical function”, parental-assessed QoL was lower 12 months after PBT versus XRT or non-RT patients.Conclusion: QoL, functional capacity, degree of obesity, and endocrinopathy varied over time from diagnosis, but by 5 years, there was no significant difference between PBT and XRT upfront or delayed, nor was there any compromise in historic survival rates, which remained high >90%. RT of any type is extremely effective at stabilizing disease after hypothalamic-sparing surgery. The purported specific benefits of PBT-reducing sequelae are not proven in this study where the organ of critical interest is itself diseased, increasing an urgent need to better address and treat the tumor-induced endocrine harm from diagnosis in dedicated pituitary services. Other hypothesized benefits of PBT versus XRT on vascular events and secondary cancers await longer comparison.Clinical trial registration number: https://clinicaltrials.gov/study/, identifier NCT01272622.Keywords
This publication has 52 references indexed in Scilit:
- On the Benefits and Risks of Proton Therapy in Pediatric CraniopharyngiomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-upEuropean Journal of Endocrinology, 2011
- Long‐term clinical outcomes following treatment of childhood craniopharyngiomaPediatric Blood & Cancer, 2010
- The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngiomaNeurosurgical Review, 2009
- Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvementJournal of neurosurgery. Pediatrics, 2007
- Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive functionJournal of neurosurgery. Pediatrics, 2006
- Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of lifeKlinische Padiatrie, 2001
- The Role of Radiotherapy in the Treatment of Craniopharyngeoma - Indications, Results, Side Effects1999
- Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?Journal of Neurosurgery, 1996